1. Arrondel, Christelle, Missoury, Sophia, Snoek, Rozemarijn, van Tilbeurgh, Herman, Mollet, Géraldine. 2019. Defects in t6A tRNA modification due to GON7 and YRDC mutations lead to Galloway-Mowat syndrome. In Nature communications, 10, 3967. doi:10.1038/s41467-019-11951-x. https://pubmed.ncbi.nlm.nih.gov/31481669/
2. Schmidt, Julia, Goergens, Jonas, Pochechueva, Tatiana, Yigit, Gökhan, Wollnik, Bernd. 2021. Biallelic variants in YRDC cause a developmental disorder with progeroid features. In Human genetics, 140, 1679-1693. doi:10.1007/s00439-021-02347-3. https://pubmed.ncbi.nlm.nih.gov/34545459/
3. Shen, Haibo, Zheng, Enkuo, Yang, Zhenhua, Li, Rui, Zhao, Guofang. 2020. YRDC is upregulated in non-small cell lung cancer and promotes cell proliferation by decreasing cell apoptosis. In Oncology letters, 20, 43-52. doi:10.3892/ol.2020.11560. https://pubmed.ncbi.nlm.nih.gov/32565932/
4. Huang, Bisheng, Zhai, Wei, Hu, Guanghui, Zhang, Jingwei, Xu, Yunfei. 2016. MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC. In American journal of translational research, 8, 4705-4715. doi:. https://pubmed.ncbi.nlm.nih.gov/27904673/
智鼠故事 
